Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAILOT: Adalimumab Optimization in Pediatric Crohn's Disease
NCT02256462Phase 4Completed
- Sponsor
- Schneider Children's Medical Center of Israel
- Start
- May 2015
- Primary completion
- Jan 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in Crohn's disease, sponsored by Schneider Children's Medical Center of Israel. Started May 2015; status: completed.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02256462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02256462.